Delea, T E <br/><br/>
Cost effectiveness of carvedilol for heart failure.  [electronic resource] 

 -  The American journal of cardiology  Mar 1999 
 - 890-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(98)01066-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--economics<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Carbazoles--economics<br/>Cardiotonic Agents--administration & dosage<br/>Carvedilol<br/>Cost-Benefit Analysis<br/>Digoxin--administration & dosage<br/>Diuretics--administration & dosage<br/>Drug Therapy, Combination<br/>Health Care Costs<br/>Heart Failure--drug therapy<br/>Hospitalization<br/>Humans<br/>Life Expectancy<br/>Markov Chains<br/>Propanolamines--economics<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Survival Rate<br/>Vasodilator Agents--economics